Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Payables: 2020-2022

Historic Payables for Atea Pharmaceuticals (AVIR) over the last 2 years, with Sep 2022 value amounting to $1.1 million.

  • Atea Pharmaceuticals' Payables fell 94.96% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.2 million, marking a year-over-year decrease of 36.88%. This contributed to the annual value of $4.5 million for FY2021, which is 7456.67% up from last year.
  • Atea Pharmaceuticals' Payables amounted to $1.1 million in Q3 2022, which was down 91.95% from $13.9 million recorded in Q2 2022.
  • Atea Pharmaceuticals' Payables' 5-year high stood at $22.2 million during Q3 2021, with a 5-year trough of $60,000 in Q4 2020.
  • In the last 3 years, Atea Pharmaceuticals' Payables had a median value of $4.5 million in 2020 and averaged $7.2 million.
  • As far as peak fluctuations go, Atea Pharmaceuticals' Payables skyrocketed by 7,456.67% in 2021, and later plummeted by 94.96% in 2022.
  • Quarterly analysis of 3 years shows Atea Pharmaceuticals' Payables stood at $60,000 in 2020, then surged by 7,456.67% to $4.5 million in 2021, then tumbled by 94.96% to $1.1 million in 2022.
  • Its Payables stands at $1.1 million for Q3 2022, versus $13.9 million for Q2 2022 and $3.7 million for Q1 2022.